Published Date: 16 Feb 2023
How is the SARS-CoV-2 mRNA antibody similar to the P.1 gamma strain and other strains?
Read Full NewsMichael Wechsler, MD, reports 59% of patients in clinical remission with twice-yearly depemokimab at year 1 maintained it at year 2 in SWIFT/AGILE.
Experts Discuss PAH Treatment Selection and Access
HCPLive Five at CHEST 2026
Kim Henriksen, PhD, discusses research evaluating blood-based biomarkers of blood-brain barrier remodeling and immune cell activity in multiple sclerosis, including their potential to track treatment responses and inform future biomarker development.
Brian Snelling, MD, director of the stroke program at Marcus Neuroscience Institute discussed delays in calling 911 after stroke onset, gaps in awareness of atypical symptoms, and how to reach underserved populations.
The clinical professor of neurology and pediatrics at The Ohio State University Wexner Medical Center discussed payer step therapy, earlier preventive treatment, and questions the updated guideline leaves open.
Shadi Yaghi, MD, FAHA, Chair of Neurology at Hackensack Meridian Neuroscience Institute at Jersey Shore University Medical Center, discusses a new calculator that predicts stroke risk within 30 days of a procedure.
1.
Finding a clue to the origin of treatment-resistant leukemia in kids
2.
How a new light-based cancer treatment could destroy tumors without harming healthy cells—using LEDs
3.
Study shows virtual reality headsets may help ease cancer pain
4.
Radiation therapy can promote amphiregulin, which increases growth of metastases
5.
Six breast texture patterns linked to higher risk of invasive cancer
1.
Management of Relapsed Synovial Sarcoma: Current Treatment Strategies and Emerging Therapies
2.
The Power of White Blood Cells: How They Help Keep Us Healthy
3.
Understanding Vaso Occlusive Crisis: Symptoms, Causes, and Management Strategies
4.
Uncovering the Reality of Colon Cancer: A Look at Real Images
5.
Immunotherapy Tolerance in Older Adults With Cancer
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Hands-on Workshop: Hematology
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
3.
Recognizing Symptoms That May Require Cancer Evaluation
4.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
5.
Navigating the Complexities of Ph Negative ALL - Part V
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation